All Episodes
Small Stocks, Big Money — 144 episodes
CEO Paul Mann on ASP Isotopes (Nasdaq: ASPI): 4 Facilities, $38B Market & Western Supply Security
Co-CEO Bob Brilon on Bimergen Energy's (NYSE: BESS) 23-Project Energy Arbitrage Pipeline
CEO Lavell Malloy on Brag House's (Nasdaq: TBH) Blockchain Sports Platform & Athlete Tokenization
CEO James Foster on Virax Biolabs' (VRAX) Long COVID Diagnostic & US Market Entry
Jeremy Schwartz CIO of WisdomTree ($WT): $165B AUM, Mega Trends & Why WT Is a Secular Growth Stock
First Phosphate (FRSPF) CEO on Agnico's $94M Bet Leaves Only 2 Independents Standing
Anixa Biosciences (ANIX): CEO on Breast Cancer Vaccine, Phase 2 Catalyst & Ovarian Cancer CAR-T Data
CEO Brandon Robinson on Horizon Aircraft’s (HOVR) Commercial eVTOL Advantages
First Phosphate (FRSPF) CEO on $16.7M Non-Dilutive Funding, LFP Batteries, and Why FRSPF Stands Out
RedChip Highlights Enlivex Therapeutics Ltd. (NASDAQ: ENLV) & Off The Hook Inc. (NYSE American: OTH)
SCAP Portfolio Manager Jay Hatfield’s Market Playbook: Fed Cuts, Core PCE, and Small Caps
Enlivex (Nasdaq: ENLV) - FY25 Financial Results Webcast Replay
Enlivex (ENLV) CEO: Two Pillars of Growth, Allocetra Knee OA Catalyst + RAIN Treasury Optionality
Off The Hook (NYSE American: OTH) CEO Interview: $145M Revenue Path, AI Boat Platform, Apex Upside
Comprehensive Healthcare Systems (CMHSF | CHS): CEO Interview on Healthcare SaaS and Pipeline Growth
The Metals Company (TMC) CFO Craig Shesky: The NOAA Path, $23.6B NPV, and US Supply Security
BioVie (Nasdaq: BIVI) CEO Cuong Do on Near Term Catalysts in Parkinson’s, Long COVID, and Ascites
First Phosphate CEO John Passalacqua: Building a North American LFP Battery Supply Chain (FRSPF)
Nexalin Technology (NXL) CEO Mark White: FDA Trials, At-Home Neurostimulation, and 2026 Milestones
OBOOK Holdings (OWLS) CEO Darren Wang on Regulated Stablecoin Payments, OwlPay Growth and 2026 Goals
NioCorp (NB) CEO Mark Smith on 2025 Milestones, Elk Creek Portal Buildout, and U.S. EXIM Financing
ASP Isotopes (Nasdaq: ASPI) Investor Webinar - January 14, 2026
Avalon Advanced Materials CEO Interview | $4B Lithium Opportunity + Rare Earth Supply Chain Upside
Alliance Entertainment (NASDAQ: AENT) Chairman on Earnings Growth and Exclusive IP Strategy
Processa Pharmaceuticals (PCSA) Interview: Phase 2 Breast Cancer Data, Pipeline Strategy & FDA Path
New Era (Nasdaq: NUAI) CEO Discusses Power, AI Data Centers, and the Next Phase of Growth
NioCorp CEO Mark Smith on U.S. Critical Minerals, Scandium Demand, and Project Financing Progress
Nova Minerals CEO: $43.4M U.S. Funding Secured, Antimony Production by 2026 and 5.2Moz Gold Resource
BullFrog AI CEO Vin Singh: Using AI to Transform Drug Discovery and Cut Development Costs
Jackpot Digital CEO Jake Kalpakian on Disrupting the Casino Industry with Dealerless Poker Tech
Connect Biopharma CEO Barry Quart: Targeting a $5B+ Market with a Next-Gen Asthma & COPD Therapy
FatPipe Networks: CEO Dr. Ragula Bhaskar on Scaling Profitable Growth in SD-WAN and Cybersecurity
60 Degrees Pharmaceuticals: CEO Geoff Dow on Breakthrough Babesiosis Therapy & FDA Path Ahead
Inside Bimergen Energy: $250M Equity Backing & 2GW BESS Pipeline with CFO Bob Brilon
Inside Nexalin: Drug-Free Neuro Tech, Clinical Milestones, and What’s Next!
Lantern Pharma CEO Panna Sharma Discusses Progress in AI-Driven Cancer Drug Development
Foremost Clean Energy CEO on Nuclear's Resurgence & 330K Acre Uranium Portfolio
PhoenixEV CEO John Walsh Interview: 2025 Goals, $200M Backlog and Transit Growth
Inside 60 Degrees Pharmaceuticals: CEO Geoffrey Dow on Revenue Growth & Pipeline Potential
Aptevo Therapeutics: Inside a Top-Tier Oncology Pipeline with COO Jeff Lamothe
Investor Insights: Calidi CEO Eric Poma Discusses Breakthroughs in Oncolytic Virotherapy
Precision Oncology at Scale: Lantern Pharma’s Strategic Vision with CEO Panna Sharma
Inside Atossa Therapeutics: CEO Dr. Steven Quay Talks Pipeline, Progress, and Investor Outlook
Inside Processa Pharma: CEO George Ng on Disrupting Oncology Drug Development
Greenwich LifeSciences' CEO on Advancing HER2+ Immunotherapy | Phase III Insights & Strategy
How Fathom Holdings Is Disrupting Real Estate with Tech & Flat-Fee Innovation | CEO Marco Fregenal
ASP Isotopes CEO Paul Mann on Transforming Global Isotope Supply for Medicine, Clean Energy, & More!
Enlivex CEO on Revolutionizing Osteoarthritis Therapy with Allocetra™ | Investor Deep Dive
Inside 60 Degrees Pharma: CEO Geoffrey Dow on Fighting Infectious Diseases & Driving Growth
Uranium & Lithium Boom: Foremost Clean Energy CEO on the Future of North America's Supply
FatPipe (Nasdaq: FATN) CEO Talks Profitability, Patented Tech & Global Growth Strategy
BioVie CEO Cuong Do on Alzheimer’s Breakthroughs, Liver Disease Pipeline & What’s Ahead
Liberty Star Minerals: Leadership Breaks Down High-Grade Gold & Copper Potential in Arizona
Inside Atossa Therapeutics (Nasdaq: ATOS): CEO Dr. Steven Quay on Advancing Breast Cancer Treatment
Inside ConnectM: How AI Is Powering the $2 Trillion Electrification Boom
bioAffinity (Nasdaq: BIAF) CEO Maria Zannes Talks CyPath® Lung, Growth & AI Innovation
Interview with Connect Biopharma CEO Barry Quart | Transforming Acute Asthma & COPD Care
BullFrog AI CEO Vin Singh on Revolutionizing Drug Development with AI-Powered Insights
LiveOne (Nasdaq: LVO) CEO Robert Ellin on Disrupting Music, Media & Monetization
Inside Nexalin: CEO Mark White on TBI Solutions & Expanding Market Potential
Inside Knightscope (Nasdaq: KSCP): CEO William Santana Li on AI, Robotics & Crime Prevention
Jupiter Neurosciences CEO Christer Rosén on Advancing Neuroinflammation Treatments & Beyond
Alliance Entertainment: Inside The Billion-Dollar Giant Powering Media Distribution Globally
Inside Calidi Biotherapeutics: CFO Andrew Jackson Breaks Down the Future of Oncolytic Virotherapy
60 Degrees Pharmaceuticals (Nasdaq: SXTP) CEO Geoffrey Dow on Expanding Malaria Prevention & Beyond
Elevating Fan-Owned Live Entertainment: VENU Founder & CEO J.W. Roth Shares His Disruptive Approach
ASP Isotopes CEO Paul Mann on Breakthrough Isotope Tech, Quantum Computing & 2025 Growth Plans
Inside Enlivex: Oren Hershkovitz on Tackling Sepsis, Osteoarthritis, and Beyond with Allocetra™
Inside Gorilla Technology: CEO Jay Chandan & Interim CFO Bruce Bower on Smart Cities & Big Data
Inside OKYO Pharma’s (NASDAQ: OKYO) Phase 2 Trials with CEO Dr. Gary Jacob
Inside VSee Health’s Telehealth Revolution: Exclusive Interview with Co-CEO Dr. Imo Aisiku
Inside Can-Fite BioPharma’s (NASDAQ: CANF) Clinical Pipeline with CEO Motti Farbstein
How MUSQ ETF is Reshaping Music Investments: CEO David Shulhof Explains
The Future of Oncology: Calidi’s Stem Cell-Based Platforms for Fighting Cancer
How Alliance Entertainment (Nasdaq AENT) is Optimizing Operations for Continued Margin Improvement
The Gold Rush of 2024: Christopher Gerteisen’s Vision for Nova Minerals and Beyond
Interview with Founder of MUSQ Global Music Industry ETF
CEO Interview: ASP Isotopes is Commercializing New Isotope Enrichment Technology
CEO Interview: Discover How OKYO Pharma is Targeting the Multi-Billion-Dollar Dry Eye Disease Market
Learn Why Soligenix has Received $60M+ in Non-Dilutive Funding From the US Government: CEO Interview
Pioneering New Osteosarcoma and Breast Cancer Treatments: Exclusive Interview with OS Therapies' CEO
CEO INTERVIEW: American Resources Corporation's Unique Ability to Refine Critical Elements
GreenPower Leverages Government Mandates and Funding to Boost Zero-Emission School Bus Line Growth
Discover Nexalin's Neurostimulation Device Targeting Mental Health Disorders
Biotricity CEO, Waqaas Al-Siddiq, on New Heart Health Innovations & the Future of Cardiac Care
Hope for Lung Cancer Patients: Cypath Lung Test's Impact
Alta Global Group: Converting MMA fans into Participants. An Interview with CEO Nick Langton
Exploring Can-Fite BioPharma's Groundbreaking Drugs: Piclidenoson and Namodenoson
Unlocking Hope: The BioVie Journey in Neurodegeneration and Liver Disease
AI Solutions in the Online CBD Industry: A 1606 Corp. Perspective
Spectaire Holdings (Nasdaq: SPEC) Launches AireCore System for Emissions Management!
Genetic Technologies: Innovating Healthcare with Genomics-based Cancer Predictions
Unlocking Growth: Exploring LOBO EV's Path to Market Leadership in E-Bikes and EVs
Enlivex's (NASDAQ:ENLV) Allocetra™: Breakthrough Macrophage Reprogramming Therapy
Biotricity (NASDAQ: BTCY) Transforming Cardiac Care: Innovative Remote Monitoring Solutions
Unlocking Growth: Lytus Technologies - Your Next Nasdaq Investment Opportunity in Digital & Healthcare Innovation!
Biotricity (NASDAQ: BTCY) Revolutionizing Cardiac Care: Meet biotricity - Leading Remote Patient Monitoring Technology
Xcel Brands (NASDAQ:XELB): Leading the Social Commerce Revolution
1606 Corp. (OTC: CBDW): Revolutionizing CBD Customer Service with AI Innovation
Mobilicom (NASDAQ: MOB) Israel Ministry of Defense Purchases Mobilicom's Game-Changing Technology!
Meet Shalabh Gupta, CEO of Unicycive Therapeutics (NASDAQ: UNCY)
The INNO (NASDAQ: INHD) Edge: Transforming Construction with Cold-Formed Steel Technology
INNO Holdings Inc. (NASDAQ: INHD) - Redefining Construction with Steel Tech
Genetic Technologies Limited (NASDAQ: GENE): Pioneering Genomics for Health and Wellness
bioAffinity Technologies: Exploring the Future of Cancer Care
Meet Maria Zannes: CEO of BioAffinity Technologies (NASDAQ: BIAF)
Innovation in Flight: Mobilicom's End-to-End Solutions for Drone Cybersecurity
How Royalty Management Transforms Undervalued Assets
Meet Kirk Taylor: CFO of Royalty Management Holding Corporation (NASDAQ: RMCO)
Meet Paul Mann: CEO & Chairman of ASP Isotopes
Meet Denton Peng: CEO & Chairman of SPI
Meet Simon Morriss: CEO of Genetic Technologies (NASDAQ: GENE)
Meet Jonathan Guarino: CFO of Soligenix (NASDAQ: SNGX)
Meet Dr. Chris Schaber: CEO & President of Soligenix (NASDAQ: SNGX)
Meet Vu Truong, Founder and CEO of Aridis Pharmaceuticals (OTC: ARDS)
Everything Blockchain: Blending Database Security & Blockchain Technologies
Sharps Technology: Targeting Niche, Multi-Billion-Dollar Markets
Continental Lithium: Addressing the Rapidly Increasing Global Demand for Lithium
Soligenix: Late-Stage Biopharma Addressing a $2 Billion Opportunity
Graphex Group: Top-10 Global Producer of Graphite Anodes
Meet Shahar Hania, CEO of Rail Vision (NASDAQ:RVSN)
Splash Beverage: Ground-Floor Opportunity with High-Growth Beverage Brands
Soligenix: A Late-Stage Biopharma Pioneer Tackling Rare Diseases with Unmet Needs
ASP Isotopes: Advanced Materials Company Targeting Isotope Production
American Resources Corporation (NASDAQ: AREC): Focusing On Critical and Rare Earth Minerals for the Electrification Market
Meet Curt Marvis, The Man Behind QYOU Media. (OTCQB: QYOUF)
Aridis Pharma Founder & CEO Discusses Upcoming Milestones for its Late-Stage Pipeline
Interview with Sixty Degrees Pharma (Nasdaq: SXTP) CEO Geoff Dow
BioVie (NASDAQ: BIVI): Poised for Significant Catalysts in 2023
Meet Vin Singh, Founder & CEO of Bullfrog AI (NASDAQ:BFRG)
The Mark Jensen Story – From Wall Street Banker to Indiana Battery Recycler - American Resources Corporation (NASDAQ:AREC)
Rail Vision (NASDAQ: RVSN): Potentially Preventing Catastrophe’s Before They Occur
American Resources Corporation (NASDAQ: AREC): How this Company Turns Trash to Treasure
SPI Energy Group (NASDAQ: SPI): Unlocking Shareholder Value Under the Sun
Biovie (NASDAQ: BIVI): Innovating Potential Alzheimer’s and Parkinson’s Treatment
How Zomedica (NYSE American: ZOM) Is Changing the Veterinary Industry with Its Cutting-Edge Diagnostics and Therapeutics
End of the Exponential Equity Growth Era? Where to Invest Next
Continental Lithium: Addressing the Rapidly Increasing Global Demand for Lithium
Reviva Pharma (NASDAQ: RVPH) Charting Success: Reviva Pharma's Journey from phase 3 to Potential NDA filing
Unlocking Precision Medicine: BullFrog AI's (Nasdaq: BFRG) Trailblazing Use of AI to Predict Therapeutic Success and Transform Drug Development
QYOU Media (OTCQB: QYOUF) Media Mavericks: The Investment Potential of QYOU Media; India's Exponentially Growing Content Powerhouse
Sharps Technology, Inc. (NASDAQ: STSS): Sustainable Solutions, Profitable Investments: Inside the No Waste Syringe Revolution
Graphex Group Ltd. (NYSE American: GRFX) Unearthed: Unveiling the Hidden Powerhouse – The Podcast Exploring Graphex Groups Dominance in the Graphite Market
Lantern Pharma (NASDAQ: LTRN): Investing in Tomorrow's Cures: Unveiling the Power of AI Drug Development Platforms